Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE studyOriginal research Published on 2022-02-032024-09-04 Journal: RMD open [Category] 대상포진, [키워드] adalimumab Arthritis cardiovascular diseases Rheumatoid Therapeutics tumor necrosis factor inhibitors [DOI] 10.1136/rmdopen-2021-002012 PMC 바로가기 [Article Type] Original research
Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapyArticle Published on 2022-02-012023-07-08 Journal: RMD Open [Category] COVID19(2023년), [키워드] COVID-19 infections tumor necrosis factor inhibitors [DOI] 10.1136/rmdopen-2021-002082 PMC 바로가기
Biologikatherapie von rheumatoider Arthritis und Spondyloarthritidenarticle Published on 2022-01-142024-09-04 Journal: Der Internist [Category] 대상포진, [키워드] Ankylosierende Spondylitis antirheumatic agents Antirheumatika Arthritis, Psoriatic interleukin Inhibitors Interleukininhibitoren Psoriasisarthritis spondylitis, ankylosing tumor necrosis factor inhibitors Tumor-Nekrose-Faktor-Inhibitoren [DOI] 10.1007/s00108-021-01248-x PMC 바로가기 [Article Type] article
Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapiesSARS-CoV2에 대한 체액 보호는 TNF 알파 차단 요법을 받는 환자에서 더 빨리 감소합니다Article Published on 2021-12-012022-09-11 Journal: RMD Open [Category] 변종, 진단, [키워드] Anti-spike anti-Spike IgG anti-TNF Antigen appearance Arthritis blockade booster booster vaccination booster vaccinations CD4+ T cell CD4+ T-cell chronic inflammatory disease chronic inflammatory diseases clinically Cohort controls COVID-19 Critical Decline declined Efficacy faster Frequency greater groups healthy controls healthy individual humoral immune response Humoral response humoral responses IgA level IgA levels IgG immune responses Inflammatory diseases lack mRNA vaccination Necrosis neutralization Neutralizing antibodies no differences pandemic Patient patients persistence receiving regimens response SARS-CoV2 second vaccination significantly T cell therapy TNF TNF alpha Treatment Tumor tumor necrosis tumor necrosis factor tumor necrosis factor inhibitors vaccination vaccine response vaccine responses variants while [DOI] 10.1136/rmdopen-2021-002008 PMC 바로가기 [Article Type] Article
Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic reviewReview Published on 2021-11-212024-09-02 Journal: International ophthalmology [Category] 대상포진, [키워드] Causality in adverse drug reactions disease-modifying antirheumatic drugs Non-steroidal anti-inflammatory drugs Ocular adverse drug reactions rheumatoid arthritis tumor necrosis factor inhibitors [DOI] 10.1007/s10792-021-02058-8 PMC 바로가기 [Article Type] Review
Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 studyOriginal research Published on 2021-10-182024-09-04 Journal: RMD open [Category] 대상포진, [키워드] adalimumab Arthritis psoriatic tumor necrosis factor inhibitors [DOI] 10.1136/rmdopen-2021-001838 PMC 바로가기 [Article Type] Original research
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort단일 중심 코호트에서 만성 염증 상태 및 면역억제 요법 환자에서 항 SARS-CoV-2 mRNA 백신의 면역원성 및 안전성Article Published on 2021-10-012022-09-12 Journal: Annals of the rheumatic diseases [Category] MERS, SARS, 진단, [키워드] age anti-SARS-CoV-2 antibody Antibody titre Arthritis binding antibody unit Cohort comparable concerning Control COVID-19 disease Effect Efficacy and safety Efficiency ELISA example group healthy control healthy controls IgG immunisation immunogenicity immunosuppressed patient immunosuppressive immunosuppressive therapy in both groups Inflammatory inflammatory condition initial mRNA vaccine mRNA vaccines national guideline Necrosis Neutralising activity pandemic Patient performed Person Protective receiving Rheumatoid risk SARS-CoV-2 severe adverse effect severe disease side Side effect significantly lower Study participants the SARS-CoV-2 therapy titre tumor necrosis factor inhibitors vaccination Vaccinations Vaccine were assessed [DOI] 10.1136/annrheumdis-2021-220272 PMC 바로가기 [Article Type] Article
Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in TaiwanOriginal Research Published on 2021-07-212024-09-02 Journal: Frontiers in Pharmacology [Category] 대상포진, [키워드] Biologic disease-modifying antirheumatic drug rheumatoid arthritis Tofacitinib treatment pattern tumor necrosis factor inhibitors [DOI] 10.3389/fphar.2021.628548 PMC 바로가기 [Article Type] Original Research
Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritisRheumatoid Arthritis Published on 2021-04-042024-09-04 Journal: Annals of the rheumatic diseases [Category] 대상포진, [키워드] adalimumab Arthritis Health care outcome assessment Rheumatoid Therapeutics tumor necrosis factor inhibitors [DOI] 10.1136/annrheumdis-2020-218412 PMC 바로가기 [Article Type] Rheumatoid Arthritis
Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trialRheumatoid Arthritis Published on 2020-09-012024-09-04 Journal: Annals of the rheumatic diseases [Category] 대상포진, [키워드] Arthritis Health care methotrexate outcome assessment Rheumatoid tumor necrosis factor inhibitors [DOI] 10.1136/annrheumdis-2020-217485 PMC 바로가기 [Article Type] Rheumatoid Arthritis